Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 965 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Vitamin Wagon adds eHGH to product line

The eHGH helps to reduce wrinkles, improve energy level, decrease fat, increase lean body mass, heighten sexual potency, sharpen the memory, improve sleep and enhance the immune system

Exelixis to begin cabozantinib Phase 3 trial

Cabozantinib inhibits MET and VEGFR2 that suppress tumor growth, metastasis and angiogenesis in preclinical models. The double-blind ‘306 trial is expected to enroll 246 CRPC patients, who will

Azantis launches new krill oil blend

The supplement contains a high amount of astaxanthin, an antioxidant that imparts the red color to krill. Astaxanthin, which is present in the cell membrane close to omega

J&J submits sNDA for Nucynta ER

The drug is an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults. The sNDA submission occurred on the back of

Infinity begins two Phase 1 IPI-145 trials

PI3K delta and gamma are the enzymes involved in immune cell functions, including cell proliferation, survival and cellular trafficking. The first Phase 1 trial of IPI-145 is a

Genedata unveils protein production data management software

Genedata Biologics advances end-to-end biologics R&D activities including antibody screening, protein engineering, and biologics production. The version 2.0 provides new protein production modules supporting production process, including molecule

Trophos begins phase II proof of concept study for TRO40303

TRO40303 causes prevention of stress-induced mitochondrial permeability transition, a target implicated in cardiac reperfusion injury. The placebo-controlled, phase II proof-of-concept study in acute MI patients with large myocardial